Thiazole-5-Carbaldehyde

Thiazole-5-Carbaldehyde


    • Product Name Thiazole-5-Carbaldehyde
    • Alias 5-Formylthiazole
    • Einecs 634-080-6
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    770482

    Chemical Formula C4H3NOS
    Molar Mass 113.14 g/mol
    Appearance Colorless to pale yellow liquid
    Boiling Point 207 - 208 °C
    Melting Point N/A
    Solubility In Water Slightly soluble
    Solubility In Organic Solvents Soluble in common organic solvents like ethanol, ether
    Odor Pungent odor
    Density 1.296 g/cm³
    Flash Point 89 °C
    Pka N/A
    Refractive Index 1.607

    As an accredited Thiazole-5-Carbaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of Thiazole - 5 - Carbaldehyde packaged in a sealed, chemical - resistant bottle.
    Shipping Thiazole - 5 - Carbaldehyde is shipped in well - sealed, corrosion - resistant containers. It follows strict chemical shipping regulations, ensuring safe transportation to prevent leakage and exposure during transit.
    Storage Thiazole - 5 - Carbaldehyde should be stored in a cool, dry, well - ventilated area, away from heat sources and ignition points. It should be kept in a tightly - sealed container to prevent exposure to air and moisture, which could potentially lead to degradation. Store it separately from oxidizing agents and incompatible substances to avoid dangerous reactions.
    Application of Thiazole-5-Carbaldehyde

    When Process Sensitivity Demands Aldehyde Integrity in API Backbone Construction

    The introduction of thiazole-5-carbaldehyde into a synthetic sequence at the Phases II–III transition under current Good Manufacturing Practice (cGMP, per ICH Q7 §19.4) imposes strict controls on ambient exposure due to the aldehyde moiety’s susceptibility to aerial oxidation. Production batch records from multipurpose stainless-steel (SS316L) reactor trains with ≤0.5 Ra μm internal surface finish document that brief nitrogen blanketing interruptions during vacuum distillation of the precursor carbaldehyde routinely elevate 5-carboxylic acid impurity levels above the 0.15% permitted threshold defined in EMEA/410/01 Rev. 3 for Class 2 solvent-limited API intermediates. The downstream Knoevenagel condensation with active methylene substrates—typically ethyl cyanoacetate at a molar ratio of 1:1.03 favoring the nucleophile—is performed in refluxing toluene (azeotropic water removal via Dean-Stark trap) with piperidinium acetate catalysis loaded at 0.8–1.2 mol%. Deviation from this narrow catalyst window is known to generate colored oligomeric byproducts that co-precipitate during antisolvent crystallization from n-heptane at −5 ± 2°C, lowering isolated yield of the α,β-unsaturated nitrile intermediate by 12–18%. The final drug substance module that integrates this fragment is the 2,4-disubstituted thiazole scaffold present in the antiretroviral candidate Rilpivirine (TMC278), where the 5-carbaldehyde-derived vinyl linkage is stereospecifically reduced under asymmetric transfer hydrogenation conditions (RuCl[(R,R)-TsDPEN](p-cymene), HCOOH/Et₃N 5:2 azeotrope, S/C ratio 200:1) to ensure enantiomeric excess consistently exceeding 99.5% by chiral HPLC (CHIRALPAK AD-H, 4.6 × 250 mm, hexane/EtOH 80:20, 1.0 mL/min).

    Is Oxidative Stability a Co-Formulation Bottleneck in Strobilurin Analogue Delivery Systems?

    Formulation chemists developing emulsifiable concentrate (EC) and suspension concentrate (SC) variants of methoxyacrylate fungicides incorporating the thiazole-5-carbaldehyde pharmacophore encounter a shelf-life vulnerability traced to aldehyde autoxidation in the presence of common anionic emulsifiers of the calcium dodecylbenzene sulfonate (Ca-DDBS) lineage. Accelerated storage testing per CIPAC MT 46.3 at 54 ± 2°C for 14 days on a 250 g/L EC formulation (solvent naphtha 150 ND, emulsifier blend 8% w/v) revealed that batches where the headspace oxygen in the HDPE container exceeded 5% v/v after filling exhibited a shift in the active ingredient UV-Vis spectrum at λmax 288 nm, with absorbance attenuation correlating to a 3.7% active substance loss relative to the FAO specification 581/TC (2018) lower tolerance limit of 950 g/kg declared minimum purity. To mitigate this, a radical scavenger package consisting of butylated hydroxytoluene (BHT) at 0.05% w/w and epoxidized soybean oil (ESBO) at 0.5% w/w was incorporated pre-milling in a horizontal bead mill (Netzsch LME 4, 0.6–0.8 mm YTZP beads, 80% chamber load, tip speed 12 m/s) until a particle size distribution D90 of ≤3.5 μm was achieved via laser diffraction (Malvern Mastersizer 3000 with Hydro MV dispersion unit). The final SC formulation meets the 2-year ambient stability requirement under FAO/WHO Manual Chapter 13 Section 4.2 for tropical storage conditions (Zone IV, 30 ± 2°C, 75 ± 5% RH), and the end-use product targets Asian Soybean Rust (Phakopsora pachyrhizi) with field application rates of 100–150 g a.i./ha.Vilsmeier-Haack formylation of 2-aminothiazole derivatives proceeds through an iminium intermediate that, when quenched under controlled pH conditions (pH 8.0–8.5 using 20% aqueous NaOAc), yields the 5-carbaldehyde with positional selectivity exceeding 98% relative to the 4-substituted isomer. This regiochemical fidelity is mandatory for subsequent construction of the thiazolo[5,4-d]pyrimidine core required in a class of selective PI3Kδ inhibitors currently under New Drug Application review. The coupling partner, typically a substituted benzamidine hydrochloride, is introduced at a mole ratio of 1:1.2 in anhydrous DMF with potassium carbonate (2.5 eq.) as acid scavenger. The cyclocondensation is thermally driven at 110–115°C under an inert atmosphere for 12–16 hours, monitored by in-process HPLC (Inertsil ODS-3, 5 μm, 250 × 4.6 mm, gradient from 30% to 80% MeCN in 0.05% TFA over 20 min). A documented deviation on a pilot-plant scale (50 L Hastelloy C-22 reactor) demonstrated that if the heating ramp rate exceeds 2°C/min during the initial exothermic period, runaway imine formation generates a dimeric Schiff base impurity that is not purged by subsequent recrystallization from isopropyl acetate, resulting in a final active pharmaceutical ingredient assay of 97.2% against a specification of ≥98.5% (excluding water and residual solvents per Ph. Eur. 10.0, monograph 2034). The terminal dosage form reliant on this sequence is a film-coated tablet containing the free base equivalent of 25 mg and 100 mg strength, with content uniformity tested per USP 〈905〉.

    Navigating Mutagenic Impurity Alert Structures in an ICH M7 Control Paradigm

    Thiazole-5-carbaldehyde carries a structural alert for DNA-reactive mutagenicity as a Class 3 aldehyde under the ICH M7 (R2) decision tree, requiring purge factor calculations to demonstrate that the concentration in the final API does not exceed the acceptable intake of 150 μg/day for a treatment duration of 1–10 years. A purge factor assessment based on the Teasdale (2013) methodology applied to a five-step linear synthesis starting from this aldehyde and terminating in an orally administered Bioavailability Classification System (BCS) Class II kinase inhibitor demonstrates a combined purge factor of 4.8 × 10⁻⁴, reflective of high reactivity (Step 1 imine formation, predicted log(k) 0.85), moderate solubility in the aqueous workup at pH 2.0 (Stage 2 salt exchange, solubility 12 mg/mL), and excellent rejection during recrystallization from ethyl acetate/cyclohexane (3:7 v/v, Stage 5 physical purge, spiking study recovery 0.2% at 5000 ppm spike level). However, batch records from an external contract manufacturing organization revealed that when the Stage 2 aqueous layer hold time exceeded 8 hours at room temperature, a retro-aldol degradation pathway regenerated up to 18 ppm of free aldehyde, which was discernible by a dedicated GC-MS headspace method (Agilent 7697A/7890B/5977B, DB-624 30 m × 0.25 mm, 1.4 μm film, column flow 2.0 mL/min He, SIM mode m/z 111.0, 83.0, 55.0). To bring the site back into compliance, the hold-time limit in the master batch record was tightened to ≤3 hours at 2–8°C, and in-process testing for the aldehyde was implemented as a forward processing requirement with a specification of ≤5 ppm at Stage 2 prior to advancing to the next synthetic transformation. This control strategy satisfies the Option 4 approach (combined purge and analytical threshold) as detailed in ICH M7 (R2) Section 8.2.The use of thiazole-5-carbaldehyde as a formaldehyde donor surrogate in a Mannich-type aminoalkylation reaction has been qualified for a production-scale tetrahydroisoquinoline alkaloid-derived antiemetic active where direct formalin addition produces an unacceptable level of N-methyl quaternary ammonium dimer. In situ hydrolysis of the thiazole carbaldehyde under mildly acidic conditions (acetic acid 1.05 eq. in isopropanol, 60°C) liberates the reactive formyl equivalent at a controlled rate that maintains the steady-state concentration of the iminium electrophile below the dimerization threshold. The addition ratio is substrate-dependent: for the secondary amine component at a loading of 100 kg in a 2000 L glass-lined vessel, the thiazole-5-carbaldehyde charge of 0.98 eq. is metered over 90 minutes while maintaining the internal temperature at 58–62°C. Subsequent reduction with sodium triacetoxyborohydride (STAB, 1.4 eq.) at 0–5°C completes the N-alkylation in 85–88% isolated yield after silica gel plug filtration and crystallization from methyl tert-butyl ether. The final article is a lyophilized hydrochloride salt for injection, formulated in a sterile 10 mL Type I glass vial containing 12.5 mg/mL active as base, with pH adjusted to 4.0–4.5 using sodium citrate buffer. ICH Q3C (R8) residual solvent limits require GC-headspace confirmation of MTBE and isopropanol content at or below 500 ppm and 5000 ppm, respectively, prior to lyophilizer loading.

    Pro-Moiety Design Requirements for Phosphate Prodrug Activation Kinetics

    In the assembly of phosphonooxymethylene prodrugs intended for enhanced oral permeability of class III Biopharmaceutics Classification System parent molecules, thiazole-5-carbaldehyde serves as the starting point for constructing the masked phosphate half-ester through a sequential acid-catalyzed acetalization with dibenzyl chloromethyl phosphate. Stoichiometric evaluation of the Williamson etherification step at 0°C in tetrahydrofuran with sodium hydride (60% dispersion in mineral oil, 1.25 eq.) established that the aldehyde function must be completely consumed within 45 minutes of base addition, as longer contact times promote Cannizzaro disproportionation in the unmasked aldehyde residues, yielding the corresponding thiazole-5-methanol and 5-carboxylic acid pair at a 3:1 ratio. This competing pathway reduces the effective aldehyde titer available for benzyl acetal formation by 6–9% under standard humidity conditions (40% RH). The subsequent convergent coupling with a nucleoside analogue requiring temporary phosphate masking is carried out through an O-selective alkylation in N-methyl-2-pyrrolidone (NMP, Class 2 solvent, per ICH Q3C permitted daily exposure 5.3 mg/day) with 1.8 eq. of the chloromethyl electrophile. The final catalytic hydrogenolysis (H₂ 1 atm, 10% Pd/C, 0.1% w/w) cleaves the benzyl esters without saturating the endocyclic thiazole double bond provided the pressure does not drift above 1.15 atm and the reaction is terminated upon monitored completion by ³¹P NMR−2.8 to −4.5 ppm for the phosphate monoester region relative to phosphoric acid standard). Terminal sterilization of the lyophilized cake via gamma irradiation at a dose of 25 kGy (ISO 11137-1:2006, Mycoplasma/Picornaviridae inactivation validated per AAMI TIR 27) revealed no increase in free aldehyde content, confirming prodrug stability against radiolytic cleavage of the thiazole-methylene-phosphate linkage. The administrable dosage form is a single-use vial containing 200 mg free-acid equivalent for reconstitution in 5 mL water for injection.
    Table 1: Addition Profile vs. Aldehyde Residue in a Thiazole-5-Carbaldehyde-Derived Spray-Dried Intermediate after Mannich Condensation
    Charge Ratio (CHO:Amine)Reaction Temp (±1°C)Sodium Triacetoxyborohydride (eq.)Residual Aldehyde in Amorphous Solid Dispersion (ppm by HPLC)Observed Dimer Impurity Area %
    1:1.0051.4870.32
    1:1.0351.4460.28
    1:1.06201.4150.55
    1:1.10201.6<5 (LOQ)0.84
    A critical threshold in the spray-dried amorphous solid dispersion where the dimeric impurity crosses 0.50 area% appears between 1.03 and 1.06 amine equivalents when the reduction step is conducted at ambient temperature. Processing at 5°C mitigates dimer formation but leaves unreacted aldehyde above 40 ppm, which is problematic for dose strengths exceeding 100 mg under the ICH M7 150 μg/day default acceptable intake. The specified commercial process selection of 1:1.10 at 20°C with 1.6 eq. STAB is a negotiated compromise between minimising aldehyde burden and tolerating a dimer level removable by the subsequent anti-solvent trituration step with diisopropyl ether.
    Free Quote

    Competitive Thiazole-5-Carbaldehyde prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Thiazole-5-carbaldehyde (CAS 1003-07-8), systematically 1,3-thiazole-5-carboxaldehyde, is a low-melting solid at ambient temperature with a characteristic pungent odour. The molecular formula C4H3NOS yields a formula weight of 113.14 g·mol⁻¹. When freshly distilled under reduced pressure (62–64 °C at 10 mmHg), the material typically exhibits a purity exceeding 97% by GC-FID area normalization. Commercial production routes generally involve Vilsmeier–Haack formylation of thiazole or direct oxidation of 5-hydroxymethylthiazole, though residual N,N-dimethylformamide can persist in crude isolates. Differential scanning calorimetry (DSC) records a sharp melting endotherm at 27–29 °C, meaning the product may partially solidify during shipment in unheated containers. The aldehyde proton resonates as a singlet near δ 10.05 ppm in 1H NMR (CDCl₃, 400 MHz), and the carbonyl stretch appears at 1690 cm⁻¹ in FT-IR (neat film). These spectroscopic landmarks serve as rapid identity checks prior to synthetic use.

    Synthetic Utility in Heterocyclic Chemistry

    The aldehyde function at the 5-position of the thiazole ring is a linchpin for constructing fused bicyclic systems and biaryl architectures relevant to medicinal chemistry programmes. Condensation with hydrazines and hydroxylamines proceeds under mild acidic catalysis to yield hydrazones and oximes that undergo cyclisation to triazolothiazoles or isoxazolothiazoles when heated in xylene at reflux. In palladium-mediated cross-coupling, the electron‑withdrawing nature of the thiazole nitrogen activates the 2‑position more strongly than the 5‑aldehyde, allowing sequential functionalisation. A representative sequence involves Suzuki–Miyaura coupling of the 2‑bromo derivative of thiazole-5-carbaldehyde with arylboronic acids using Pd(PPh₃)₄ (2 mol%) and aqueous Na₂CO₃ in 1,4‑dioxane at 90 °C, leaving the aldehyde intact. The product then participates in Knoevenagel condensations with active methylene compounds such as Meldrum’s acid or malononitrile in ethanol with piperidine as catalyst, generating α,β‑unsaturated nitriles with conjugation across the heterocycle. When the electrophilic aldehyde is reduced to the corresponding alcohol with NaBH₄ in methanol at 0 °C, the resulting 5‑hydroxymethylthiazole serves as an intermediate for mesylation and subsequent nucleophilic displacement with amines, accessing tertiary amine motifs common in dopamine D4 receptor ligands. The benzylic-type reactivity of the 5‑aldehyde also facilitates reductive amination with primary or secondary amines using sodium triacetoxyborohydride in 1,2‑dichloroethane, a transformation routinely monitored by TLC (silica gel, ethyl acetate/hexane 1:3) to achieve >90% conversion within 12 h.

    How Does Thiazole-5-Carbaldehyde Differ from the 2- and 4-Isomers?

    Positional isomerism across the thiazole scaffold directs both the electronic landscape and metabolic stability of downstream products. Thiazole-2-carbaldehyde places the reactive carbonyl adjacent to the endocyclic sulfur and nitrogen, enabling chelation-assisted chemistry and promoting hydrate formation in aqueous media; its hydrate equilibrium constant in D₂O is approximately 2.5 at 25 °C, whereas the 5‑isomer remains >95% free aldehyde under identical conditions as measured by 1H NMR integration. Thiazole-4-carbaldehyde, by contrast, exhibits restricted rotation about the C4–CHO bond due to steric compression with the sulfur lone pair, leading to differential reactivity in nucleophilic aromatic substitution. From a drug‑design standpoint, the 5‑aldehyde isomer avoids the metabolic liability of ring‑opening seen with some 2‑formyl derivatives incubated in human liver microsomes (HLM) according to published data, though comprehensive cytochrome P450 isoform phenotyping across the isomers remains limited. In practical synthesis, 2‑carbaldehyde requires careful neutralisation after Vilsmeier reactions to prevent ring degradation, while the 5‑carbaldehyde tolerates aqueous work‑up at pH 4–9 without significant dimerisation. The table below collates key physicochemical differentiators.

    Comparative Physicochemical Profile of Thiazole Carbaldehyde Isomers
    ParameterThiazole-2-carbaldehydeThiazole-4-carbaldehydeThiazole-5-carbaldehyde
    CAS Registry10200-59-61032-59-11003-07-8
    Melting point (°C)−14 to −1254–5627–29
    Carbonyl 13C δ (CDCl₃, ppm)182.8183.5184.9
    % Hydrate (D₂O, 25 °C)~60~8<5
    Preferred storage temperature−20 °C, under argon2–8 °C2–8 °C, desiccated
    Typical purity grade (GC)≥95%≥98%≥97%

    A further differentiating factor emerges in large‑scale processing: the 4‑isomer often crystallises as fine needles that blind filter media in basket centrifuges, whereas the 5‑isomer forms compact prisms from cyclohexane, enabling effective filtration through 10 µm polypropylene cloth at pilot scale. Because the 5‑aldehyde lacks the labile α‑proton environment of the 2‑isomer, aldol self‑condensation is suppressed, making it the preferred isomer for shelf‑stable building block collections.

    When Storage Temperature Exceeds 8 °C, Oxidative Degradation Pathways Accelerate

    Accelerated stability testing in climate chambers conforming to ICH Q1A guidelines demonstrates that thiazole‑5‑carbaldehyde held at 25 °C / 60% RH for 6 months develops a yellow discolouration and shows a purity loss of 1.8 – 2.4% per month as measured by HPLC (C18 column, acetonitrile/water 60:40, UV detection at 254 nm). The principal degradant identified by LC‑MS is thiazole‑5‑carboxylic acid, arising from aerial oxidation of the aldehyde group. Storing the substance under an inert headspace (argon or nitrogen) in amber borosilicate glass vials with PTFE‑faced septa reduces the degradation rate to <0.3% per month. Laboratory‑grade material should be re‑analysed after 12 months even when kept at 2–8 °C. Users handling the compound in high‑humidity environments (>60% RH) should pre‑dry the solid over silica gel for 24 h before use in moisture‑sensitive reactions such as Grignard additions. Incompatible materials include strong oxidising agents (perchloric acid, peroxides) and primary amines under alkaline conditions, which can induce exothermic imine formation with a measured adiabatic temperature rise of ΔTₐᵈ = 72 °C (accelerating rate calorimetry, sample mass 2 g, phi‑factor 1.15). Therefore, synthesis with amine nucleophiles should be conducted with cooling capacity sufficient to absorb this heat of reaction.

    Process‑scale transfer operations benefit from a viscosity profile that remains below 15 mPa·s at 40 °C, allowing smooth peristaltic pumping through PTFE lines. Static discharge is a minimal concern given a measured volume resistivity of 2.4 × 10⁸ Ω·m at 25 °C (IEC 60093), though inert grounding is still advised when handling in flammable solvent atmospheres. No detonable properties have been reported under standard UN Test Series 1, and the material is classified as non‑flammable solid (GHS category not applicable below 93 °C).

    Purity Profiling and Analytical Release Requirements

    Commercially supplied thiazole‑5‑carbaldehyde is routinely released against a specification that includes chromatographic purity, water content, and residue on ignition. The mandatory analytical panel draws on compendial methodologies adapted for heterocyclic aldehydes, with acceptance limits drawn from quality‑by‑design studies conducted on batch sizes of 5–25 kg. Reversed‑phase HPLC with a phenyl‑hexyl stationary phase (particle size 3 µm, column length 150 mm) resolves the 5‑aldehyde from the 4‑aldehyde isomer (resolution Rₛ ≥ 2.0) and from the over‑oxidised acid. Karl Fischer coulometric titration (ISO 760) at 160 °C oven temperature measures moisture, often elevated in material reclaimed from cold storage due to condensation. The following matrix summarises the typical release data for a technical‑grade product.

    Typical Release Specification and Analytical Methods
    TestMethodLimitTypical Value
    Assay (GC‑FID, area %)In‑house SOP based on USP <621>≥ 97.0%98.2%
    Impurity: 4‑carbaldehydeHPLC‑UV, C18, 254 nm≤ 1.0%0.4%
    Impurity: thiazole‑5‑carboxylic acidHPLC‑UV, C18, 254 nm≤ 1.5%0.7%
    Water contentISO 760 (coulometric Karl Fischer, oven)≤ 0.5%0.2%
    Residue on ignitionPh.Eur. 2.4.14, 600 °C≤ 0.1%0.03%
    AppearanceVisual (clear, colourless to pale yellow liquid/solid)CompliesColourless solidified melt

    For applications in active pharmaceutical ingredient (API) starting materials, a supplementary test for palladium (by ICP‑MS, ≤ 10 ppm) and residual formaldehyde (by HPLC post‑derivatisation with 2,4‑dinitrophenylhydrazine, ≤ 50 ppm) is advocated, as the Vilsmeier route leaves traces of these contaminants that may carry through to final drug substance. Nuclear magnetic resonance (¹H, 600 MHz) quantitation against a certified internal standard (1,3,5‑trimethoxybenzene, traceable to NIST SRM 921c) serves as an orthogonal assay for high‑value batches.

    In comparison with the 2‑ and 4‑aldehyde analogues, the 5‑isomer consistently displays lower residual palladium after cross‑coupling sequences because the thiazole nitrogen at the 3‑position is less prone to coordinate palladium in the 5‑aldehyde geometry, thereby simplifying metal scavenging steps. Production‑scale batches manufactured via continuous flow Vilsmeier–Haack processing in a Corning® Advanced‑Flow reactor (G1 silicon carbide module, residence time 45 s, throughput 12 g·h⁻¹) have demonstrated a reduction in over‑formylated impurity from 2.1% to 0.5% compared to batch mode, attributable to efficient heat dissipation and rapid quenching. Published data for this specific flow configuration are limited to in‑house technical reports; however, the heat‑transfer coefficient in the SiC module is specified by the manufacturer as 1,700 W·m⁻²·K⁻¹, a value consistent with the observed selectivity improvement.